𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Can antiviral agents decrease the occurrence of Kaposi's sarcoma?

✍ Scribed by D. Costagliola; M. Mary-Krause; Clinical Epidemiology Group

Book ID
118558446
Publisher
The Lancet
Year
1995
Tongue
English
Weight
156 KB
Volume
346
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Occurrence of primary cancers in associa
Occurrence of primary cancers in association with multiple myeloma and Kaposi's sarcoma in the United States, 1973–1995
✍ Michael J. Cannon; W. Dana Flanders; Philip E. Pellett πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 55 KB πŸ‘ 3 views

The causes of multiple myeloma (MM) are obscure, but a laboratory association was recently reported between MM and human herpesvirus 8 (HHV-8), the probable etiologic agent of Kaposi's sarcoma (KS). Although there has been some additional laboratory corroboration, most laboratory studies have found

Non-human immunodeficiency virus Kaposi'
Non-human immunodeficiency virus Kaposi's sarcoma can be effectively treated with low-dose interferon-Ξ± despite the persistence of herpesvirus-8
✍ Deichmann; Thome; JΓ„ckel; Utermann; Bock; Waldmann; NΓ„her πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

Three patients, negative for human immunodeficiency virus (HIV), with histologically and polymerase chain reaction-proven non-HIV Kaposi's sarcoma who received low-dose interferon (IFN) as first-line treatment because of disseminated symptomatic disease are reported. Applying 3-18 million IU of IFN-